The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Primary sclerosing cholangitis: Natural history, prognostic factors and survival analysis
Open accessAbstract
The natural history of primary sclerosing cholangitis was assessed in 174 patients; 37 were asymptomatic and 137 had symptoms related to underlying liver disease. At the time of diagnosis, the mean age was 39.9 years, 66% of the primary sclerosing cholangitis patients were male and 71% had associated inflammatory bowel disease, most commonly chronic ulcerative colitis. Longterm follow-up (mean: 6.0 years; range: 2.7 to 15.5 years) was available in all patients. During follow-up, 59 (34%) of the patients died: 55 in the symptomatic group and four in the asymptomatic group. Median survival from the time of diagnosis of primary sclerosing cholangitis at the Mayo Clinic was 11.9 years. Survival in the asymptomatic group was significantly decreased compared with that in a control population matched for age, race and sex. Multivariate analysis (Cox proportional hazards regression modeling) revealed that age, serum bilirubin concentration, blood hemoglobin concentration, presence or absence of inflammatory bowel disease and histologic stage on liver biopsy were independent predictors of high risk of dying. The development of a multivariate statistical survival model is a major step in identifying individual primary sclerosing cholangitis patients at low, moderate and high risk of dying. Such models will be useful for stratifying patients in therapeutic trials, in patient counseling and in patient selection and timing of liver transplantation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Compensated cirrhosis: Natural history and prognostic factors
Ginés, P., Quintero, E., Arroyo, V., Terés, J., Bruguera, M., Rimola, A., Caballería, J., Rodés, J., & Rozman, C. (1987) · Hepatology · doi:10.1002/hep.1840070124 · Cited by 1,106
Chapman, R. W., Arborgh, B. A., Rhodes, J. M., Summerfield, J. A., Dick, R., Scheuer, P. J., & Sherlock, S. (1980) · Gut · doi:10.1136/gut.21.10.870 · Cited by 732
Clinicopathologic features of the syndrome of primary sclerosing cholangitis
Wiesner, R. H., & LaRusso, N. F. (1980) · Gastroenterology · doi:10.1016/0016-5085(80)90131-6 · Cited by 550
Self-citationBeneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis
Christensen, E., Neuberger, J., Crowe, J., Altman, D. G., Popper, H., Portmann, B., Doniach, D., Ranek, L., Tygstrup, N., & Williams, R. (1985) · Gastroenterology · doi:10.1016/0016-5085(85)90213-6 · Cited by 423
Roll, J., Boyer, J. L., Barry, D., & Klatskin, G. (1983) · New England Journal of Medicine · doi:10.1056/nejm198301063080101 · Cited by 417
Multivariate survival analysis using Cox's regression model
Christensen, E. (1987) · Hepatology · doi:10.1002/hep.1840070628 · Cited by 366
Primary Sclerosing Cholangitis
LaRusso, N. F., Wiesner, R. H., Ludwig, J., & MacCarty, R. L. (1984) · New England Journal of Medicine · doi:10.1056/nejm198404053101407 · Cited by 353
Self-citationPrimary Sclerosing Cholangitis: A Long-Term Follow-up Study
Aadland, E., Schrumpf, E., Fausa, O., Elgjo, K., Heilo, A., Aakhus, T., & Gjone, E. (1987) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528709011139 · Cited by 276
Orthotopic Liver Transplantation for Primary Sclerosing Cholangitis
MARSH, J. W., IWATSUKI, S., MAKOWKA, L., ESQUIVEL, C. O., GORDON, R. D., TODO, S., TZAKIS, A., MILLER, C., THIEL, D. V., & STARZL, T. E. (1988) · Annals of Surgery · doi:10.1097/00000658-198801000-00005 · Cited by 253
SUGI supplemental library user's guide
Hastings, R. P. (1986) · SAS Institute eBooks · Cited by 228
Sclerosing Cholangitis in Ulcerative Colitis
Schrumpf, E., Elgjo, K., Fausa, O., Gjone, E., Kolmannskog, F., & Ritland, S. (1980) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528009181516 · Cited by 206
Primary Sclerosing Cholangitis
Dickson, R. E., Larusso, N. F., & Wiesner, R. H. (1984) · Hepatology · doi:10.1002/hep.1840040711 · Cited by 194
Self-citationWiesner, R. H., Larusso, N. F., Ludwig, J., & Rolland Dickson, E. (1985) · Gastroenterology · doi:10.1016/s0016-5085(85)80141-4 · Cited by 193
Self-citationWee, A., Ludwig, J., Coffey, R. J., LaRusso, N. F., & Wiesner, R. H. (1985) · Human Pathology · doi:10.1016/s0046-8177(85)80158-1 · Cited by 191
Self-citationProspective trial of penicillamine in primary sclerosing cholangitis
LaRusso, N. F., Wiesner, R. H., Ludwig, J., MacCarty, R. L., Beaver, S. J., & Zinsmeister, A. R. (1988) · Gastroenterology · doi:10.1016/0016-5085(88)90180-1 · Cited by 172
Self-citationPrognostic Factors in Cirrhosis Identified by Cox's Regression Model
Schlichting, P., Christensen, E., Andersen, P. K., Fauerholdt, L., Juhl, E., Poulsen, H., & Tygstrup, N. (1983) · Hepatology · doi:10.1002/hep.1840030601 · Cited by 171
Improved survival with primary sclerosing cholangitis
Helzberg, J. H., Petersen, J. M., & Boyer, J. L. (1987) · Gastroenterology · doi:10.1016/0016-5085(87)90618-4 · Cited by 166
Lenz, H. J., Burlage, M., Raedler, A., & Greten, H. (1988) · Gastroenterology · doi:10.1016/0016-5085(88)90229-6 · Cited by 147
Ulcerative Colitis and Persistent Liver Dysfunction
Shepherd, H. A., Selby, W. S., Chapman, R. W., Nolan, D. J., Barbatis, C., McGee, J. O., & Jewell, D. P. (1983) · QJM · doi:10.1093/oxfordjournals.qjmed.a067776 · Cited by 139
A course in nonparametric statistics
Hájek, J. (1969) · Cited by 134
Abnormalities in tests of copper metabolism in primary sclerosing cholangitis
Gross, J. B., Ludwig, J., Wiesner, R. H., McCall, J., & LaRusso, N. F. (1985) · Gastroenterology · doi:10.1016/0016-5085(85)90326-9 · Cited by 87
Self-citationIntrahepatic cholangiectases and large-duct obliteration in primary sclerosing cholangitis
Ludwig, J., MacCarty, R. L., LaRusso, N. F., Krom, R. A. F., & Wiesner, R. H. (1986) · Hepatology · doi:10.1002/hep.1840060403 · Cited by 83
Self-citationKaplan, M. M., ARORA, S., & PINCUS, S. H. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-2-231 · Cited by 78
Outcome of primary sclerosing cholangitis. Analysis of long-term observation of 38 patients
Lebovics, E. (1987) · Archives of Internal Medicine · doi:10.1001/archinte.147.4.729 · Cited by 69
Long-standing asymptomatic primary sclerosing cholangitis report of three cases
Chapman, R. W., Burroughs, A. K., Bass, N. M., & Sherlock, S. (1981) · Digestive Diseases and Sciences · doi:10.1007/bf01309608 · Cited by 46
Cited by
Diagnosis and Management of Primary Sclerosing Cholangitis
Chapman, R., Fevery, J., Kalloo, A., Nagorney, D. M., Boberg, K. M., Shneider, B., & Gores, G. J. (2010) · Hepatology · doi:10.1002/hep.23294 · Cited by 1,224
Primary sclerosing cholangitis – a comprehensive review
Karlsen, T. H., Folseraas, T., Thorburn, D., & Vesterhus, M. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.07.022 · Cited by 868
MELD and PELD: Application of survival models to liver allocation
Wiesner, R. H., McDiarmid, S. V., Kamath, P. S., Edwards, E. B., Malinchoc, M., Kremers, W. K., Krom, R. A. F., & Kim, R. W. (2001) · Liver Transplantation · doi:10.1053/jlts.2001.25879 · Cited by 864
Self-citationNatural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis.
Broomé, U., Olsson, R., Lööf, L., Bodemar, G., Hultcrantz, R., Danielsson, A., Prytz, H., Sandberg-Gertzén, H., Wallerstedt, S., & Lindberg, G. (1996) · Gut · doi:10.1136/gut.38.4.610 · Cited by 819
High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis
Lindor, K. D., Kowdley, K. V., Luketic, V. A. C., Harrison, E. M., McCashland, T., Befeler, A. S., Harnois, D., Jorgensen, R., Petz, J., Keach, J., et al. (2009) · Hepatology · doi:10.1002/hep.23082 · Cited by 720
Metadata
- Authors
- Wiesner, R. H., Grambsch, P. M., Dickson, R. E., Ludwig, J., Maccarty, R. L., Hunter, E. B., Fleming, T. R., Fisher, L. D., Beaver, S. J., & Larusso, N. F.
- Venue
- Hepatology
- Published
- 1989-10
- Volume
- 10
- Issue
- 4
- Pages
- 430-436
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W1996463505
- Cited by
- 643
- References
- 25
- FWCI
- 8.14
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.